Angelalign to Appeal Chinese Court Decision
Angelalign Technology Inc. announced its intention to appeal a first-instance judgment by the Jinan Intermediate People's Court regarding a premolar extraction solution. The company stated the decision has no impact on customers.
Angelalign Technology Inc. said it will appeal a first-instance judgment issued by the Jinan Intermediate People's Court on August 10. The ruling concerns a premolar extraction solution utilized by Angelalign's Chinese subsidiaries.
The company stated in a press release that the court's decision will not affect its customers. Angelalign indicated that the appeals process is underway and expressed confidence in achieving a favorable outcome.
Premolar extraction is a common practice in orthodontic treatment, often employed in more complex cases to facilitate tooth movement and improve bite alignment. The implications of this ruling for the company's operations and market standing are under review.
Angelalign, listed on the Hong Kong Stock Exchange (6699.HK), operates within China's orthodontics sector. The company's response to the legal challenge and its potential broader impact on the industry are being closely monitored.